Expanding the Versatility of Cardiac PET/CT: Feasibility of Delayed Contrast Enhancement CT for Infarct Detection in a Porcine Model

It has recently been suggested that, similar to MRI, CT can be used to detect infarcts at high resolution by delayed myocardial contrast enhancement. In cardiac PET/CT, this ability to detect infarcts may increase the versatility and integrative potential of PET and CT study components. We sought to determine the feasibility of delayed CT-enhancement in the PET/CT environment and compared it with PET-defined rest perfusion for the measurement of infarct size. Methods: Experimental myocardial infarction was induced in 10 young farm pigs by occlusion and reperfusion of the left anterior descending coronary artery. After 4–6 wk, the animals underwent 64-slice PET/CT. Rest perfusion was measured by 13N-ammonia PET. Then, 120 mL of contrast were injected, and retrospectively gated helical CT was performed for angiography and after 1.5-, 5-, 10-, and 15-min delays. Two days later, 6 pigs again underwent contrast-enhanced CT, using a low-radiation-dose approach (prospective gating and thicker slices as used for clinical calcium scoring) and the same delay times. Polar maps of PET perfusion and CT myocardial enhancement were created for further analysis. Results: CT Hounsfield units (HUs) in the infarct area started to exceed those of arterial blood at 5–10 min after contrast injection, and the ratios of infarcted myocardium to remote myocardium and of infarcted myocardium to blood plateaued at around 1.9 and 1.2 between 10 and 15 min. Excellent agreement between high- and low-dose CT acquisitions (R = 0.87, P < 0.001) was demonstrated. At 10 min, CT infarct size (area with HU > 3.5 SDs from remote) was 30% ± 8% of the left ventricle, using the low-dose approach. The PET perfusion defect size (area with uptake < 60% of the left ventricular maximum) was comparable at 31% ± 8% of the left ventricle (range, 17%−44%). Using a 16-segment myocardial model, we showed an excellent inverse relationship between regional ammonia retention and contrast enhancement (R = −0.93, P < 0.001). Conclusion: In our animal model, infarct size can be measured accurately and reproducibly using cardiac PET/CT with delayed CT-enhancement. For measurement, a low-dose, prospectively gated acquisition was comparable to higher-dose spiral CT. These results provide a rationale for further clinical work to explore whether delayed CT-enhancement can improve the accuracy of myocardial viability assessment, substitute for rest studies in perfusion imaging, or improve localization of PET-derived molecular signals.

[1]  M. Javadi,et al.  Lowering radiation dose for integrated assessment of coronary morphology and physiology: First experience with step-and-shoot CT angiography in a rubidium 82 PET-CT protocol , 2008, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[2]  H. Halperin,et al.  Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction. , 2008, Journal of the American College of Cardiology.

[3]  S. Nekolla,et al.  Assessment of alphavbeta3 integrin expression after myocardial infarction by positron emission tomography. , 2008, Cardiovascular research.

[4]  Udo Hoffmann,et al.  Reperfused myocardial infarction: contrast-enhanced 64-Section CT in comparison to MR imaging. , 2008, Radiology.

[5]  Jiang Hsieh,et al.  Prospectively gated transverse coronary CT angiography versus retrospectively gated helical technique: improved image quality and reduced radiation dose. , 2008, Radiology.

[6]  C. Kramer,et al.  Late gadolinium-enhanced cardiac magnetic resonance , 2008, Current cardiology reports.

[7]  Randall C. Thompson,et al.  Radiation Dose to Patients From Cardiac Diagnostic Imaging , 2007, Circulation.

[8]  S. Moore,et al.  Clinical Myocardial Perfusion PET/CT* , 2007, Journal of Nuclear Medicine.

[9]  C. Claussen,et al.  Sixty-four-MSCT in the characterization of porcine acute and subacute myocardial infarction: determination of transmurality in comparison to magnetic resonance imaging and histopathology. , 2007, European journal of radiology.

[10]  Jeroen J. Bax,et al.  Role of imaging in cardiac stem cell therapy. , 2007, Journal of the American College of Cardiology.

[11]  M. D. Di Carli,et al.  New technology for noninvasive evaluation of coronary artery disease. , 2007, Circulation.

[12]  Filippo Cademartiri,et al.  Assessment of acute reperfused myocardial infarction with delayed enhancement 64-MDCT. , 2007, AJR. American journal of roentgenology.

[13]  Stephen L. Bacharach,et al.  Positron emission tomography myocardial perfusion and glucose metabolism imaging , 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[14]  W. Stevenson,et al.  Characterization of the Peri-Infarct Zone by Contrast-Enhanced Cardiac Magnetic Resonance Imaging Is a Powerful Predictor of Post–Myocardial Infarction Mortality , 2006, Circulation.

[15]  Gabriel P Krestin,et al.  Multislice computed tomography and magnetic resonance imaging for the assessment of reperfused acute myocardial infarction. , 2006, Journal of the American College of Cardiology.

[16]  Roger B. Davis,et al.  Impact of Unrecognized Myocardial Scar Detected by Cardiac Magnetic Resonance Imaging on Event-Free Survival in Patients Presenting With Signs or Symptoms of Coronary Artery Disease , 2006, Circulation.

[17]  Bénédicte Belge,et al.  Characterization of Acute and Chronic Myocardial Infarcts by Multidetector Computed Tomography: Comparison With Contrast-Enhanced Magnetic Resonance , 2006, Circulation.

[18]  Henry R. Halperin,et al.  Contrast-Enhanced Multidetector Computed Tomography Viability Imaging After Myocardial Infarction: Characterization of Myocyte Death, Microvascular Obstruction, and Chronic Scar , 2006, Circulation.

[19]  Yasuo Ohashi,et al.  Assessment of reperfused acute myocardial infarction with two-phase contrast-enhanced helical CT: prediction of left ventricular function and wall thickness. , 2005, Radiology.

[20]  J. Knuuti,et al.  EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[21]  Stephan G Nekolla,et al.  Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: comparison with single-photon emission tomography using Tc99m-sestamibi. , 2005, Journal of the American College of Cardiology.

[22]  Stefan Neubauer,et al.  Value of Delayed-Enhancement Cardiovascular Magnetic Resonance Imaging in Predicting Myocardial Viability After Surgical Revascularization , 2004, Circulation.

[23]  Udo Hoffmann,et al.  Acute myocardial infarction: contrast-enhanced multi-detector row CT in a porcine model. , 2004, Radiology.

[24]  R. Kim,et al.  Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study , 2003, The Lancet.

[25]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[26]  O. Simonetti,et al.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.

[27]  Stephan G. Nekolla,et al.  Reproducibility of polar map generation and assessment of defect severity and extent assessment in myocardial perfusion imaging using positron emission tomography , 1998, European Journal of Nuclear Medicine.

[28]  E. Fallen,et al.  Can nitrogen-13 ammonia kinetic modeling define myocardial viability independent of fluorine-18 fluorodeoxyglucose? , 1997, Journal of the American College of Cardiology.

[29]  R. Judd,et al.  Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. , 1995, Circulation.

[30]  J. Votaw,et al.  Estimation of left ventricular mass and infarct size from nitrogen-13-ammonia PET images based on pathological examination of explanted human hearts. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  O. Ratib,et al.  Noninvasive detection of functionally significant coronary artery stenoses with exercise and positron emission tomography. , 1991, American heart journal.

[32]  D E Kuhl,et al.  Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. , 1990, Journal of the American College of Cardiology.

[33]  M E Phelps,et al.  13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. , 1989, Circulation.

[34]  H. Schelbert,et al.  Insights Into Coronary Artery Disease Gained From Metabolic Imaging , 1988, Circulation.